Format

Send to

Choose Destination
Am J Speech Lang Pathol. 2008 Nov;17(4):401-15. doi: 10.1044/1058-0360(2008/07-0047). Epub 2008 Oct 7.

Defining, identifying, and evaluating clinical trials of stuttering treatments: a tutorial for clinicians.

Author information

1
Australian Stuttering Research Centre, The University of Sydney, Gate 2 East Street, Lidcombe, NSW, Australia. m.onslow@usyd.edu.au

Abstract

PURPOSE:

To develop a method for clinicians to evaluate stuttering treatment efficacy research with very little burden of work.

METHOD:

The clinical trial is the most fundamental, clinically interpretable, and useful output unit of stuttering treatment research. We define a clinical trial of a stuttering treatment and specify 3 levels of clinical trials evidence. We use this taxonomy to identify and evaluate clinical trials of stuttering treatment. Our taxonomy draws on 2 fundamental principles of clinical trials used to evaluate health care: randomization and effect size.

RESULTS:

Published clinical trials of stuttering treatments were identified and allocated to 1 of 3 levels of evidence.

CONCLUSIONS:

We outline a 3-step, semi-automated, Internet-based method to identify the publication of a report of stuttering treatment efficacy. For a report identified as such, a 10-item checklist is applied to verify its status as a clinical trial and to allocate it to 1 of 3 levels of clinical trials evidence. The present taxonomy reduces the burden of work of a 136-item checklist in an existing taxonomy.

PMID:
18840700
DOI:
10.1044/1058-0360(2008/07-0047)
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Atypon
Loading ...
Support Center